ClinConnect ClinConnect Logo
Search / Trial NCT05201209

LASER FiLaC™ (FISTULA LASER CLOSURE) : First-line Treatment of Complex Anal Fistulas

Launched by FONDATION HÔPITAL SAINT-JOSEPH · Jan 20, 2022

Trial Information

Current as of May 24, 2025

Completed

Keywords

Fistula Laser Sphincter

ClinConnect Summary

A first retrospective study was conducted in the medical and surgical proctology department of the Hospital Group Paris Saint-Joseph on a cohort on 69 consecutive patients seen between May 2016 ans April 2017 and treated by FiLaC™ for a complex anal fistula. This technique has thus cured 60% of patients with superior trans-sphincter fistula. No incontinence-type complications were observed. These results, all the interesting as it was a learning phase, led the investigators to continue to use FiLaC™, which is currently practiced by all the team's practitioners as a first-line sphincter savi...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient with complex anal fistula treated by the FiLaC™ between 05/01/17 and 05/01/18
  • Exclusion Criteria:
  • Patient scheduled for treatment by FiLaC™ and collected as such but finally treated by fistulotomy given a fistula pathway considered intraoperatively less complex than expected
  • Patient with recto vaginal or vaginal skin fistula
  • Patient under guardianship or curators
  • Patient deprived of liberty
  • Patient objecting to the use of their data for this research

About Fondation Hôpital Saint Joseph

Fondation Hôpital Saint-Joseph is a dedicated clinical trial sponsor committed to advancing healthcare and improving patient outcomes through innovative research. Located in a reputable healthcare institution, the foundation collaborates with healthcare professionals and researchers to conduct high-quality clinical trials across various medical fields. By fostering a culture of scientific excellence and patient-centered care, Fondation Hôpital Saint-Joseph aims to contribute valuable insights to the medical community and enhance the quality of treatments available to patients.

Locations

Paris, Ile De France, France

Patients applied

0 patients applied

Trial Officials

Vincent De PARADES, M.D

Principal Investigator

Fondation Hôpital Saint-Joseph

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials